HealingWell.com - Community, Information, Resources
HOME  |  DISEASES & CONDITIONS  |  VIDEOS  |  FORUMS & CHAT  |  RESOURCES  |  NEWSLETTER  |  BOOKSTORE  |  JOIN
WHAT'S NEW  |  SUBMIT SITE  |  DONATE  |  HW SHOP  |  ADVERTISE  |  ABOUT US  |  EMAIL  |  SEARCH
 
Search Site:    
Search Archives:      




Return to Topic Area:
Welcome Page
 
Search
 E-Mail to a colleague
Modern Medicine - A New Resource for Busy Physicians & Healthcare Professionals
Click Here to Learn More

Dealing with diagnostic difficulties in CTCL
Source: Dermatology Times
By: Bill Gillette
Originally published: March 1, 2005

New Orleans — For a variety of reasons, cutaneous T-cell lymphoma (CTCL) — a low-grade lymphoma that typically presents in or on the skin — can be difficult to diagnose.

CTCL should not be confused with peripheral T-cell lymphomas (PTL) or adult T-cell lymphoma/leukemia (ATLL), which are more aggressive forms of lymphoma that may also present initially in or on the skin but require different types of treatment. Thus, accurate diagnosis is crucial.

According to Jacqueline M. Junkins-Hopkins, M.D., CTCL features overlap with more inflammatory dermatoses, making them difficult to differentiate from the pseudolymphoma and, as a result, often making accurate diagnosis problematic. In addition, she says, histopathology of the early disease is not always diagnosable, so that CTCL and its variants may escape diagnosis entirely.

Dr. Junkins-Hopkins, assistant professor, University of Pennsylvania Health System's department of dermatology, provided insight on the topic at the 63rd Annual Meeting of the American Academy of Dermatology here.

Types and traits Dr. Junkins-Hopkins notes that CTCL presents itself as two main types: classic mycosis fungoides (MF) and non-mycosis fungoides or non-epidermotropic CTCL. She also says there are a multitude of MF variants, among which are:

  • pagetoid reticulosis
  • folliculotropic MF, with or without mucinosis
  • granulomatous slack skin
  • hypopigmented
  • syringotropic/syringolymphoid hyperplasia
  • palmar plantar
  • bullous

Further, she identifies four variants of erythrodermic T-cell lymphoma — Sezary syndrome (an advanced form of MF), erythrodermic MF, ATLL, and HIV-related HTLV II — and notes what she refers to as "clonal disorders":

  • large and small plaque parapsoriasis
  • lymphomatoid papulosis
  • acute and chronic pityriasis lichenoides
  • clonal cutaneous lymphoid hyperplasia
  • clonal dermatitis

As to the clinical approach to CTCL infiltrates, Dr. Junkins-Hopkins says it should focus on history (duration, site, morphology and drugs, as well as course/treatment response); possible previous biopsies; and new biopsies.

"Often, more than one biopsy is necessary. They should be repeated if the histology is non-specific, and the deep-sampling variety is helpful," she says. "Adjunctive tests also are often needed."

Dr. Junkins-Hopkins adds that in the case of classic patch/plaque CTCL, or MF, if the clinical presentation points to MF, non-diagnostic histology is acceptable. In any case, she stresses, "Communication between clinician and pathologist is critical."

Typical histology of CTCL-MF, Dr. Junkins-Hopkins notes, includes the following features:

  • irregular proliferation of rete or atrophy
  • epidermotropism ("beading" of lymphocytes along the basal keratinocytes and/or "stuffing" of dermal papilla by collections of atypical lymphocytes)
  • Pautrier's microabcess
  • absence of epidermal alteration (spongiosis, lichenoid tissue reaction)
  • cerebriform lymphocytes with perinuclear halos pepper epidermis with minimal spongiosis
  • papillary dermal fibroplasias
  • lymphocytes patchy to band-like, initially sparing vascular plexus below papillary dermis

Patch/plaque MF histologic simulators include:

  • spongiatic dermatosis (allergic contact dermatitis, eczema)
  • pigmented purpora/lichen striatus
  • lichenoid keratosis
  • lichenoid dermatosis
  • drug-induced cutaneous lymphoid hyperplasia
  • lichen sclerosis
  • normal skin/no pathology/non-specific chronic inflammation (especially if partially treated)

For the not-so-typical Dr. Junkins-Hopkins also notes various "not so typical" CTCL-MF histology showing "normal skin" or mild, non-specific lymphocyte infiltrate. For a partially treated disease, steroid diminishes epidermotropism, and there should be a re-sample off topicals after about six weeks. With folliculotropic or syringotropic MF, she says, it may well be perivascular if no adnexae in the plane of sections exist. Also under the category of not-so-typical histology, Dr. Junkins-Hopkins says there is often an overlap of other inflammatory dermatoses, such as:

  • lichenoid MF, which may have a lichenoid-tissue reaction similar to LP, requiring consultation and correlation with the clinician
  • pigmented purpora MF, the clinical and histologic features of which may overlap
  • spongiotic MF

Conclusion Dr. Junkins-Hopkins says clinicians should follow these guidelines for accurate diagnosis of CTCL:

  • Awareness of CTCL variants and clinical-pathologic correlation and dialogue facilitate the diagnosis
  • Biopsy off topical therapy increases the diagnostic yield
  • Assessing levels through the biopsy to assess for follicles may be needed to exclude follicular MF
  • Unilesional CTCL may have a different prognosis than classic patch/plaque MF.



 E-Mail to a colleague
A new resource for time-starved physicians and healthcare professionals
Modern Medicine - Click Here
Search
Return to Topic Area:
Welcome Page
 


Privacy Policy Disclaimer Copyright Editorial Policy Sponsorship Policy All Topics
   Powered by Mediwire

 Sponsor:



 Bookstore
WellnessBooks.com - Books on Chronic Illness


 Sponsor


We subscribe to the HONcode principles of the Health On the Net FoundationWe subscribe to the HONcode principles of the Health On the Net Foundation   Visit WellnessBooks.com »
Home | Diseases & Conditions | Videos | Forums & Chat | Resources | Newsletter | Bookstore | Join
What's New | Submit Site | Donate | HW Shop | Advertise | About Us | Email | Search
Link to HealingWell
 
Privacy Policy & Disclaimer. ©1996-2005 HealingWell.com  All rights reserved.